id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2006-D-0356-0004,FDA,FDA-2006-D-0356,Draft Guidance for Industry and Food and Drug Administration Staff; Class II Special Controls Guidance Document: Absorbable Hemostatic Device; Availability; Reopening of Comment Period,Notice,NEC-Notice of Extension,2008-09-11T04:00:00Z,2008,9,2008-09-11T04:00:00Z,2008-10-15T03:59:59Z,2024-11-12T04:19:51Z,E8-21197,1,0,09000064806ff38c